Company: LPSN
Filing Date: 2025-09-17
Form Type: DEF 14A
Source: 0001102993-25-000159
Chunk: 26

Company: LIVEPERSON INC
Filing Date: 2025-09-17
Form: DEF 14A
Chunk 26
---
 Market under the symbol “LPSN.”

Effect on Par Value

The proposed amendments to our Charter will not affect the par value of our common stock, which will remain at $0.001 per share.

Reduction in Stated Capital

As a result of the Reverse Stock Split, upon the Effective Time, the stated capital on our balance sheet attributable to our common stock, which consists of the par value per share of our common stock multiplied by the aggregate number of shares of our common stock issued and outstanding, will be reduced in proportion to the size of the Reverse Stock Split; the reduction will be subject to a minor adjustment in respect of the treatment of fractional shares, and the additional paid-in capital account will be credited with the amount by which the stated capital is reduced. Our stockholders’ equity, in the aggregate, will remain unchanged.

Effect on Preferred Stock

As of the record date, we have outstanding 26,551 shares of Series B Preferred Stock. Pursuant to our existing Charter, our authorized stock includes a total of 5,000,000 shares of preferred stock, $0.001 par value per share. The proposed Reverse Stock Split will not impact the number of outstanding shares of Series B Preferred Stock, the total authorized number of shares of Series B Preferred Stock or the par value of the Series B Preferred Stock. However, the proposed Reverse Stock Split will decrease the conversion ratio applicable to the Series B Preferred Stock by the Final Ratio.

Effect on Warrants

As of the record date, we have outstanding warrants exercisable for 14,658,647 shares of our common stock. The proposed Reverse Stock Split will decrease the number of shares of our common stock that may be purchased on exercise of such warrants, and correspondingly increase the warrant exercise price, by the Final Ratio.

As of the record date, we have outstanding warrants exercisable with respect to a notional amount of 234,673 shares of our common stock for cash payments equal to the excess of “fair market value” (as

#### 18 Proxy Statement
Proposal No. 1: Reverse Stock Split Proposal

defined therein) per share over the strike price. The proposed Reverse Stock Split will decrease the notional amount of such warrants, and correspondingly increase the warrant exercise price, by the Final Ratio.

Effect on Our Convertible Notes

As of the record date, we have outstanding $20.1 million in aggregate principal amount of 0% Convertible Notes due in December 2026 (“2026 Notes”), convertible at the option of